A Spatiotemporal Organ-Wide Gene Expression and Cell Atlas of the Developing Human Heart.

gene expression heart development human development human developmental cell atlas in situ sequencing single-cell RNA-sequencing spatial transcriptomics spatially resolved transcriptomics

Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
12 Dec 2019
Historique:
received: 28 06 2018
revised: 06 09 2019
accepted: 14 11 2019
entrez: 14 12 2019
pubmed: 14 12 2019
medline: 6 6 2020
Statut: ppublish

Résumé

The process of cardiac morphogenesis in humans is incompletely understood. Its full characterization requires a deep exploration of the organ-wide orchestration of gene expression with a single-cell spatial resolution. Here, we present a molecular approach that reveals the comprehensive transcriptional landscape of cell types populating the embryonic heart at three developmental stages and that maps cell-type-specific gene expression to specific anatomical domains. Spatial transcriptomics identified unique gene profiles that correspond to distinct anatomical regions in each developmental stage. Human embryonic cardiac cell types identified by single-cell RNA sequencing confirmed and enriched the spatial annotation of embryonic cardiac gene expression. In situ sequencing was then used to refine these results and create a spatial subcellular map for the three developmental phases. Finally, we generated a publicly available web resource of the human developing heart to facilitate future studies on human cardiogenesis.

Identifiants

pubmed: 31835037
pii: S0092-8674(19)31282-6
doi: 10.1016/j.cell.2019.11.025
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1647-1660.e19

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Michaela Asp (M)

Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden. Electronic address: michaela.asp@scilifelab.se.

Stefania Giacomello (S)

Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden; Department of Biochemistry and Biophysics, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Stockholm University, Stockholm, Sweden.

Ludvig Larsson (L)

Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.

Chenglin Wu (C)

Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.

Daniel Fürth (D)

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.

Xiaoyan Qian (X)

Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.

Eva Wärdell (E)

Department of Medicine, Karolinska Institutet, Huddinge, Sweden.

Joaquin Custodio (J)

Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

Johan Reimegård (J)

Department of Cell and Molecular Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Fredrik Salmén (F)

Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, the Netherlands.

Cecilia Österholm (C)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Patrik L Ståhl (PL)

Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.

Erik Sundström (E)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, R&D Unit, Stockholms Sjukhem, Stockholm, Sweden.

Elisabet Åkesson (E)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, R&D Unit, Stockholms Sjukhem, Stockholm, Sweden.

Olaf Bergmann (O)

Center for Regenerative Therapies Dresden, TU-Dresden, Dresden, Germany; Karolinska Institutet, Cell and Molecular Biology, Stockholm, Sweden.

Magda Bienko (M)

Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

Agneta Månsson-Broberg (A)

Department of Medicine, Karolinska Institutet, Huddinge, Sweden.

Mats Nilsson (M)

Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.

Christer Sylvén (C)

Department of Medicine, Karolinska Institutet, Huddinge, Sweden.

Joakim Lundeberg (J)

Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden. Electronic address: joakim.lundeberg@scilifelab.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH